| | Mastropietro KF, Rogers JM, Paltin D, Umlauf A, Grelotti DJ, Fitzgerald RL, Grant I, Marcotte TD. Exploration of sex differences in cannabis use patterns, driving performance, and subjective intoxication effects. International Neuropsychological Society annual meeting, 02-04-2023. | | | Rogers JM, Grant I, Marcondes MC, Morgan EE, Cherner M, Ellis RJ, Letendre SL, Heaton RK, Iudicello JE. Methamphetamine, cannabis, HIV, and their combined effects on neurocognition. International Neuropsychological Society annual meeting, 02-04-2023. | | | Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Sobolesky PM, Smith BE, Hoffman MA, Hubbard JA, Severson J, Huestis MA, Grant I, Fitzgerald RL. Cannabis, driving performance and users'' perception of safety: A double-blind, placebo-controlled randomized clinical trial of smoked cannabis. International Neuropsychological Society annual meeting, 02-03-2022. | | | Watson CW, Morgan EE, Paolillo EW, Ellis RJ, Letendre S, Grant I. Recent cannabis use is associated with lower levels of inflamatory chemokines MCP-1 and IP-10 in CSF among people living with HIV. International Neuropsychological Society annual meeting, 02-05-2020. | | | Ellis R, Iudicello J, Morgan E, Henry B, Schrier R, Cherner M, Hoenigl M, Letendre SL. (2019). Beneficial effects of cannabis on blood brain barrier and inflammation in HIV. CROI. | | | Fields J, Ovale E, Swinton M, Spencer B, Coban H, Valera E, Alexeeva A, Gough S, Soontornniyomkij B, Masliah E, Achim C, Desplats P. HIV promotes a pro-inflammatory phenotype in brain macrophage that may be reduced by cannabinoids. International Symposium on NeuroVirology, 04-10-2018. |  | Ellis R, Li Y, Peterson S, Schrier R, South E, Iudicello J, Letendre S, Morgan EE, Cherner M, Grant I. Recent cannabis use in HIV infection is associated with reduced IL-16 in CSF. International Symposium on NeuroVirology, 04-10-2018. |
|